# Urica Therapeutics, Inc. — Form D

Urica Therapeutics, Inc. of BAY HARBOR ISLANDS, FL, a company, filed a Form D exempt-offering notice with the SEC on 2023-01-05. The offering totals $5.0M, of which $2.5M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2023-01-05
- Form: D
- Accession: 0001959861-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $2.5M
- Remaining: $2.5M
- Investors: 26
- Date of first sale: 2022-12-27
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-469777

## Issuer

- Name: Urica Therapeutics, Inc.
- CIK: 0001959861
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 1111 KANE CONCOURSE, BAY HARBOR ISLANDS, FL, 33154
- Phone: 781-652-4500

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Jay D Kranzler, M.D., Ph.D. | Director | Bay Harbor Islands, FL |
| Lindsay A Rosenwald, M.D. | Director | WORCESTER, MA |
| Vibeke S Strand, M.D. | Director | Bay Harbor Islands, FL |
| Michael S Weiss | Director | New York, NY |
| Raymond S Zheng | Director | Bay Harbor Islands, FL |
| Jay D Kranzler, M.D., Ph.D. | Executive Officer | Bay Harbor Islands, FL |
| Raymond S Zheng | Executive Officer | Bay Harbor Islands, FL |

## More

- [CIK 1959861 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1959861&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001959861-23-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.